Target intelligence / Profile preview

RNA, U6 small nuclear 1019, pseudogene (RNU6-1019P)

Target: RNU6-1019P
Molecular classification: Other (Processed pseudogene; small nuclear RNA pseudogene)

Overview

RNU6-1019P is a processed pseudogene derived from the U6 small nuclear RNA gene. U6 snRNA itself is an essential noncoding RNA component of the spliceosome, participating in pre-mRNA splicing, but RNU6-1019P does not encode a functional RNA or protein. Pseudogenes like RNU6-1019P are often created through retrotransposition events, such as LINE-1 (L1)-mediated reverse transcription, resulting in genomic copies lacking regulatory function. While pseudogenes can serve as evolutionary markers or as evidence of retrotransposition dynamics, they do not serve canonical biological or therapeutic roles. In summary, RNU6-1019P should not be considered a therapeutic target; it is a nonfunctional genomic sequence derived from a noncoding RNA parent and does not encode an active molecule for receptor, enzyme, or other drug targeting purposes.

Other names: RNU6-1019PRNA, U6 small nuclear 1019, pseudogene

Biological functions

Other (Pseudogenes, especially of snRNAs, are generally nonfunctional remnants and do not have active biological roles. Their parental gene, U6 snRNA, is crucial for mRNA splicing, but the pseudogene itself is not functionally active)

Disease associations

Other (No established role in disease. Pseudogenes can sometimes be markers of retrotransposition activity but are not directly implicated in disease processes)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1019, pseudogene (RNU6-1019P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1019, pseudogene (RNU6-1019P).

Explore the full profile